Need help finding what you are looking for?
Contact Us
PUBLISHER: GlobalData | PRODUCT CODE: 1271078
PUBLISHER: GlobalData | PRODUCT CODE: 1271078
Thoracic Aortic Stent Grafts Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
PUBLISHED:
PAGES: 77 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Abstract
GlobalData's Medical Devices sector report, "Thoracic Aortic Stent Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Thoracic Aortic Stent Grafts pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Thoracic aortic stent grafts are used to treat thoracic aortic aneurysms by reinforcing a part of the aorta using a minimally invasive procedure.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Thoracic Aortic Stent Grafts under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Thoracic Aortic Stent Grafts and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Thoracic Aortic Stent Grafts under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Product Code: GDME1520EPD
Table of Contents
1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Introduction
- 2.1 Thoracic Aortic Stent Grafts Overview
3 Products under Development
- 3.1 Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
- 3.2 Thoracic Aortic Stent Grafts - Pipeline Products by Territory
- 3.3 Thoracic Aortic Stent Grafts - Pipeline Products by Regulatory Path
- 3.4 Thoracic Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
- 3.5 Thoracic Aortic Stent Grafts - Ongoing Clinical Trials
4 Thoracic Aortic Stent Grafts - Pipeline Products under Development by Companies
- 4.1 Thoracic Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
- 4.2 Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
5 Thoracic Aortic Stent Grafts Companies and Product Overview
- 5.1 APT Medical Inc Company Overview
- 5.1.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.2 Artivion Inc Company Overview
- 5.2.1 Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.3 Beijing Tianzhu Ruichang Medical Technology Co Ltd Company Overview
- 5.3.1 Beijing Tianzhu Ruichang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.4 EndoSpan Ltd Company Overview
- 5.4.1 EndoSpan Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.5 Evasc Medical Systems Corp Company Overview
- 5.5.1 Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview
- 5.6 Hangzhou Endonom Medtech Co Ltd Company Overview
- 5.6.1 Hangzhou Endonom Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.7 JOTEC GmbH Company Overview
- 5.7.1 JOTEC GmbH Pipeline Products & Ongoing Clinical Trials Overview
- 5.8 Lombard Medical Technologies Inc. Company Overview
- 5.8.1 Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
- 5.9 Lundquist Company Overview
- 5.9.1 Lundquist Pipeline Products & Ongoing Clinical Trials Overview
- 5.10 Medtronic Plc Company Overview
- 5.10.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
- 5.11 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
- 5.11.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
- 5.12 St. Jude Medical LLC Company Overview
- 5.12.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
- 5.13 Terumo Aortic Company Overview
- 5.13.1 Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview
- 5.14 TriVascular Inc Company Overview
- 5.14.1 TriVascular Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.15 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
- 5.15.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6 Thoracic Aortic Stent Grafts- Recent Developments
- 6.1 Apr 06, 2023: Merit Medical Systems to Announce First Quarter 2023 Results on April 26, 2023
- 6.2 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
- 6.3 Feb 23, 2023: LeMaitre Q4 2022 Financial Results
- 6.4 Feb 03, 2023: Merit Medical Systems to Announce Fourth Quarter and Year End 2022 Results and Issue Fiscal Year 2023 Guidance on February 22, 2023
- 6.5 Jan 30, 2023: Medtronic appoints Michael Blackwell as India vice-president
- 6.6 Dec 07, 2022: Cook Medical welcomes Dr. John A. Kaufman as Chief Medical Officer
- 6.7 Nov 23, 2022: Medtronic Reports Quarterly Earnings
- 6.8 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
- 6.9 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
- 6.10 Oct 17, 2022: LeMaitre Will Announce Third Quarter 2022 Earnings Results October 27, 2022
- 6.11 Oct 13, 2022: Merit Medical Systems to Announce Third Quarter Results on October 26, 2022
- 6.12 Sep 07, 2022: Medtronic to appear at September investor conferences
- 6.13 Aug 31, 2022: LeMaitre to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
- 6.14 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
- 6.15 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
- 6.16 Jul 28, 2022: LeMaitre Q2 2022 Financial Results
- 6.17 Jul 27, 2022: Merit Medical Reports Results for Quarter Ended June 30, 2022
- 6.18 Jul 18, 2022: LeMaitre Will Announce Second Quarter 2022 Earnings Results July 28, 2022
- 6.19 Jul 14, 2022: Merit Medical Systems to Announce Second Quarter Results on July 27, 2022
- 6.20 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director
- 6.21 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
- 6.22 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
- 6.23 Apr 28, 2022: LeMaitre Q1 2022 Financial Results
- 6.24 Apr 27, 2022: Merit Medical Reports Results for Quarter Ended March 31, 2022
- 6.25 Apr 21, 2022: Merit Medical Announces Chief Operating Officer Transition
7 Appendix
- 7.1 Methodology
- 7.2 About GlobalData
- 7.3 Contact Us
- 7.4 Disclaimer
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.